SGNT Insider Trading Activity and SEC Form 4 Filings
SGNT insider trading summary
No open-market insider purchases or sales of Sagent Pharmaceuticals, Inc. (SGNT) have been reported on SEC Form 4 in the past 12 months.
Latest SGNT insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Apr 21, 2016 | Vivo Ventures Vi Affiilates Fund, L.P. | 10% Owner | Sell | $230 (17 @ $13.55) |
| Apr 21, 2016 | Vivo Ventures V, LLC | 10% Owner | Sell | $27K (1,982 @ $13.55) |
| Apr 21, 2016 | Vivo Ventures VI, LLC | 10% Owner | Sell | $230 (17 @ $13.55) |
| Apr 21, 2016 | Vivo Ventures Fund VI, L.P. | 10% Owner | Sell | $230 (17 @ $13.55) |
| Apr 21, 2016 | Vivo Ventures V Affiliates Fund, L.P. | 10% Owner | Sell | $27K (1,982 @ $13.55) |
| Apr 21, 2016 | Vivo Ventures Vi Affiilates Fund, L.P. | 10% Owner | Sell | $230 (17 @ $13.55) |
| Apr 21, 2016 | Vivo Ventures Fund VI, L.P. | 10% Owner | Sell | $31K (2,299 @ $13.55) |
| Apr 21, 2016 | Vivo Ventures VI, LLC | 10% Owner | Sell | $31K (2,299 @ $13.55) |
| Apr 21, 2016 | Vivo Ventures Vi Affiilates Fund, L.P. | 10% Owner | Sell | $31K (2,299 @ $13.55) |
| Apr 21, 2016 | Vivo Ventures Fund V, L.P. | 10% Owner | Sell | $27K (1,982 @ $13.55) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.